{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:57:44Z","timestamp":1776959864735,"version":"3.51.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,25]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Increasing evidences support the effectiveness of traditional Chinese medicine (TCM) in the treatment of nonalcoholic fatty liver disease (NAFLD), but it involves a wide variety of therapeutic methods. We aimed to evaluate the efficacy and safety of the TCM-based clearing heat and laxative (CHL) Method for intervention in NAFLD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Randomized controlled trials (RCTs) of CHL method for NAFLD were included. We searched Pubmed, Scopus, Web of science, CNKI, CBM, VIP, Wanfang databases from the inception to October 2023. We performed separate meta-analyses of clinical outcomes for liver enzymes, lipid profile, and total efficiency. The quality of the evidence was assessed with the Cochrane risk of bias tool. This study is registered on INPLASY, number INPLASY2022100002.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nine trials involving 856 participants were included in this meta-analysis. The meta-analysis showed that compared with the control group, the experimental group was more conducive to ameliorating the levels of ALT [MD\u2005=\u2005\u22128.00, 95% CI (\u22129.43, \u22126.56), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001], AST [MD\u2005=\u2005\u22127.41, 95% CI (\u22128.75, \u22126.07), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001], GGT [MD\u2005=\u2005\u221229.41, 95% CI (\u221242.25, \u221216.56), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001], TC [MD\u2005=\u2005\u22120.76, 95% CI (\u22121.18, \u22120.35), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0003], TG [MD\u2005=\u2005\u22120.54, 95% CI (\u22120.82, \u22120.27), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0001], HDL-C [MD\u2005=\u20050.15, 95% CI (\u22120.01, 0.31), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.07], LDL-C [MD\u2005=\u2005\u22120.47, 95% CI (\u22120.62, \u22120.32), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001], and the total effective rate [OR\u2005=\u20053.11, 95% CI (1.94, 4.99), <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001]. Adverse events were observed in 2 trials, mainly milder gastrointestinal symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Significant differences in the clinical efficacy were found between the experimental and control groups in treating NAFLD. Thus, the TCM-based CHL method brings significant advantages in treating NAFLD. Further, it is recommended that patients in NAFLD with abnormal liver enzymes be treated with CHL for at least 3 months, and the proportion of laxatives in TCM prescription can be appropriately increased to improve the overall curative effect.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042189","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T23:00:40Z","timestamp":1745881240000},"page":"e42189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of traditional Chinese medicine-based clearing heat and laxative method against nonalcoholic fatty liver disease: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6229-411X","authenticated-orcid":false,"given":"Ya-Nan","family":"Qu","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-8957","authenticated-orcid":false,"given":"Yan-Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Gastroenterology, The Third Affiliated Clinical Hospital to Changchun University of Chinese Medicine, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Tong","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Yuan","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bethune Third Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-2747","authenticated-orcid":false,"given":"Chao-Ran","family":"Bi","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hainan Medical University, Haikou, Hainan Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease.","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/hep.32072","article-title":"Nonalcoholic fatty liver disease and cardiac remodeling risk: pathophysiological mechanisms and clinical implications.","volume":"74","author":"Zhou","year":"2021","journal-title":"Hepatology (Baltimore)"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology (Baltimore)"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","article-title":"Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases.","volume":"126","author":"Cai","year":"2020","journal-title":"Circ Res"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"e3661","DOI":"10.1210\/clinem\/dgac382","article-title":"Fibrosis risk in nonalcoholic fatty liver disease is related to chronic kidney disease in older type 2 diabetes patients.","volume":"107","author":"Sun","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease.","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metab Clin Exp"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"13219","DOI":"10.3390\/ijms222413219","article-title":"The new therapeutic approaches in the treatment of non-alcoholic fatty liver disease.","volume":"22","author":"Filipovic","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature.","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.","volume":"16","author":"Dai","year":"2021","journal-title":"Chin Med"},{"key":"R11-20250904","first-page":"37","article-title":"Research progress of traditional Chinese medicine in non-alcoholic fatty liver disease.","volume":"21","author":"Feifan","year":"2023","journal-title":"Life Sci Instrum"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"1005318","DOI":"10.3389\/fcimb.2022.1005318","article-title":"Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet.","volume":"12","author":"Bi","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R14-20250904","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1139\/y98-049","article-title":"The gut as a potential trigger of exercise-induced inflammatory responses.","volume":"76","author":"Marshall","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"584090","DOI":"10.3389\/fphar.2020.584090","article-title":"Da-Chai-Hu decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease through remodeling the gut microbiota and modulating the serum metabolism.","volume":"11","author":"Cui","year":"2020","journal-title":"Front Pharmacol"},{"key":"R16-20250904","first-page":"2887","article-title":"Study on the effect of Yinchenhao decoction on non-alcoholic fatty liver model rats based on serum metabonomics.","volume":"31","author":"Yi-qing","year":"2020","journal-title":"Lishizhen Med Mater Med Res"},{"key":"R17-20250904","article-title":"Cochrane handbook for systematic reviews of interventions.","author":"Higgins"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13643-017-0663-8","article-title":"Evaluations of the uptake and impact of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and extensions: a scoping review.","volume":"6","author":"Page","year":"2017","journal-title":"Syst Rev"},{"key":"R19-20250904","article-title":"Efficacy of traditional chinese medicine-based clearing heat and laxative method against non-alcoholic fatty liver disease: a systematic review and meta-analysis.","author":"Bi","journal-title":"Inplasy Protocol"},{"key":"R20-20250904","first-page":"1364","article-title":"Clinical observation on 56 cases of nonalcoholic fatty liver complicated with metabolic syndrome treated with ninggan decoction.","volume":"19","author":"Songhua","year":"2013","journal-title":"J Basic Chin Med"},{"key":"R21-20250904","first-page":"750","article-title":"Clinical study of Yinqin clearing liver and lowering lipid decoction in treatment of nonalcoholic fatty liver disease.","volume":"37","author":"Wong","year":"2019","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R22-20250904","first-page":"31","article-title":"Clinical observation on 34 cases with non-alcohol fatty liver disease by lipid-lowering and anti-hepatic fibrosis decoction.","volume":"18","author":"Xiao","year":"2012","journal-title":"Guiding J Tradit Chin Med Pharm"},{"key":"R23-20250904","first-page":"1137","article-title":"Clinical observation on 60 cases of nonalcoholic fatty liver treated with ganzhiping decoction.","volume":"34","author":"Xu","year":"2012","journal-title":"Hebei J Tradit Chin Med"},{"key":"R24-20250904","first-page":"61","article-title":"Clinical efficacy of Yinchenhao Tang combined with Sinisan in treating nonalcoholic fatty liver disease with hyperhomocysteinemia.","volume":"25","author":"Feng","year":"2019","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"R25-20250904","first-page":"1100","article-title":"Clinical observation of Yinchen Yueju decoction in the treatment of nonalcoholic steatohepatitis.","volume":"5","author":"Huang","year":"2008","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R26-20250904","first-page":"44","article-title":"Clinical study on the prevention and treatment of non-alcoholic steatohepatitis with Xiaozhi Jianpi mixture.","volume":"9","author":"Lin","year":"2010","journal-title":"Tradit Chin Med J"},{"key":"R27-20250904","first-page":"115","article-title":"Effects of modified Yinchenhao decoction on intestinal microecology in patients with NAFLD of damp-heat syndrome.","volume":"48","author":"Liu","year":"2021","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R28-20250904","first-page":"112","article-title":"Effect of modified Yinchenhao decoction on glucose, lipid and uric acid metabolism for patients with nonalco-holic fatty liver disease.","volume":"36","author":"Zhao","year":"2018","journal-title":"J Sichuan Tradit Chin"},{"key":"R29-20250904","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756283X13484078","article-title":"Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial.","volume":"6","author":"Eckard","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"key":"R30-20250904","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14712598.2018.1518424","article-title":"Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response.","volume":"18","author":"Delaune","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"R31-20250904","doi-asserted-by":"crossref","first-page":"875700","DOI":"10.3389\/fphar.2022.875700","article-title":"Revealing the mechanism of huazhi rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"R32-20250904","first-page":"4138555","article-title":"Comparative efficacy of chinese patent medicines for clearing heat and dampness in the treatment of NAFLD: a network meta-analysis of real-world evidence.","volume":"2022","author":"Xu","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"R33-20250904","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12967-022-03495-4","article-title":"Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome.","volume":"20","author":"Wu","year":"2022","journal-title":"J Transl Med"},{"key":"R34-20250904","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1152\/ajpendo.00332.2010","article-title":"Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.","volume":"300","author":"Sheng","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R35-20250904","doi-asserted-by":"crossref","first-page":"114340","DOI":"10.1016\/j.jep.2021.114340","article-title":"Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.","volume":"279","author":"Shen","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R36-20250904","first-page":"225","article-title":"Meta-analysis on Cassiae Semen-Containing Chinese herbal compound preparations in treatment of nonalcoholic fatty liver.","volume":"17","author":"Huang","year":"2017","journal-title":"Eval Anal Drug-Use Hosp China"},{"key":"R37-20250904","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s42003-021-02883-8","article-title":"Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota.","volume":"4","author":"Luo","year":"2021","journal-title":"Commun Biol"},{"key":"R38-20250904","doi-asserted-by":"crossref","first-page":"e0138078","DOI":"10.1371\/journal.pone.0138078","article-title":"Co-administration of cholesterol-lowering probiotics and anthraquinone from cassia obtusifolia L. Ameliorate non-alcoholic fatty liver.","volume":"10","author":"Mei","year":"2015","journal-title":"PLoS One"},{"key":"R39-20250904","first-page":"1654","article-title":"Experiment study of total anthraquinone in cassiae semen on lipid peroxidation and PPAR-gamma expression in liver tissues of rats with alcoholic fatty liver.","volume":"36","author":"Luo","year":"2011","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R40-20250904","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.3390\/nu12123612","article-title":"POCU1b, the n-butanol soluble fraction of polygoni cuspidati rhizoma et radix, attenuates obesity, non-alcoholic fatty liver, and insulin resistance via inhibitions of pancreatic lipase, cAMP-dependent PDE activity, AMPK activation, and SOCS-3 suppression.","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"key":"R41-20250904","first-page":"1188","article-title":"Effects of polydatin on nonalcoholic fatty liver and related molecular mechanisms.","volume":"35","author":"Liu","year":"2019","journal-title":"Chin J Immunol"},{"key":"R42-20250904","doi-asserted-by":"crossref","first-page":"113849","DOI":"10.1016\/j.biopha.2022.113849","article-title":"In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction-associated fatty liver disease.","volume":"156","author":"Yu","year":"2022","journal-title":"Biomed Pharmacother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:04:39Z","timestamp":1756987479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":41,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042189","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}